English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience

Eichhorn, F., Klotz V, L., Kriegsmann, M., Bischoff, H., Schneider, M. A., Muley, T., et al. (2021). Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. LUNG CANCER, 153, 150-157. doi:10.1016/j.lungcan.2021.01.018.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Eichhorn, Florian, Author
Klotz V, Laura, Author
Kriegsmann, Mark, Author
Bischoff, Helge, Author
Schneider, Marc A., Author
Muley, Thomas, Author
Kriegsmann, Katharina, Author
Haberkorn, Uwe, Author
Heussel, Claus Peter, Author
Savai, Rajkumar1, Author           
Zoernig, Inka, Author
Jaeger, Dirk, Author
Thomas, Michael, Author
Hoffmann, Hans, Author
Winter, Hauke, Author
Eichhorn, Martin E., Author
Affiliations:
1Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591698              

Content

show

Details

show
hide
Language(s):
 Dates: 2021-01-202021-03-01
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: LUNG CANCER
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 153 Sequence Number: - Start / End Page: 150 - 157 Identifier: ISSN: 0169-5002